EX-FILING FEES
Published on March 1, 2022
Exhibit 107.1
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Sutro Biopharma, Inc.
(Exact Name of Registrant as Specified in its Charter)
Newly Registered Securities
Security Type | Security Class Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee |
|
||||||||
Equity | Common stock, par value $0.001 per share |
Rule 457(c) and Rule 457(h) |
2,316,303 (2) | $8.41 (3) | $19,480,109.00 | $0.0000927 | $1,806.00 | |||||||||
Equity | Common stock, par value $0.001 per share |
Rule 457(c) and Rule 457(h) |
463,260 (4) | $7.15 (5) | $3,312,309.00 | $0.0000927 | $308.00 | |||||||||
Total Offering Amounts | $22,792,418.00 |
$N/A | $2,114.00 | |||||||||||||
Total Fee Offsets | | |||||||||||||||
Net Fee Due | $2,114.00 |
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the Securities Act), this Registration Statement shall also cover any additional shares of the Registrants common stock that become issuable under the Registrants 2018 Equity Incentive Plan (the 2018 EIP) and 2018 Employee Stock Purchase Plan (2018 ESPP) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrants receipt of consideration that increases the number of the outstanding shares of the Registrants common stock. |
(2) | Represents additional shares to be registered and available for grant under the 2018 EIP resulting from the annual 5% automatic increase in the number of authorized shares available for issuance under the 2018 EIP. |
(3) | Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The proposed maximum offering price per share of $8.41 was computed by averaging the high and low prices of a share of Registrants common stock as reported on The Nasdaq Global Market on February 23, 2022. |
(4) | Represents additional shares to be registered and available for grant under the 2018 ESPP resulting from the annual 1% automatic increase in the number of authorized shares available for issuance under the 2018 ESPP. |
(5) | Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The proposed maximum offering price per share of $7.15 was computed by averaging the high and low prices of a share of Registrants common stock as reported on The Nasdaq Global Market on February 23, 2022, multiplied by 85%, which is the percentage of the trading price per share applicable to purchasers under the 2018 ESPP. |